Jones K - Search Results

1

The impact of HLA class I and EBV latency-II antigen-specific CD8(+) T cells on the pathogenesis of EBV(+) Hodgkin lymphoma.

Jones K, Wockner L, Brennan RM, Keane C, Chattopadhyay PK, Roederer M, Price DA, Cole DK, Hassan B, Beck K, Gottlieb D, Ritchie DS, Seymour JF, Vari F, Crooks P, Burrows SR, Gandhi MK. Jones K, et al. Clin Exp Immunol. 2016 Feb;183(2):206-20. doi: 10.1111/cei.12716. Epub 2015 Nov 13. Clin Exp Immunol. 2016. PMID: 26422112 Free PMC article.

2

HLA class I associations with EBV+ post-transplant lymphoproliferative disorder.

Jones K, Wockner L, Thornton A, Gottlieb D, Ritchie DS, Seymour JF, Kumarasinghe G, Gandhi MK. Jones K, et al. Transpl Immunol. 2015 Mar;32(2):126-30. doi: 10.1016/j.trim.2015.02.005. Epub 2015 Feb 27. Transpl Immunol. 2015. PMID: 25731678 Clinical Trial.

3

Sodium valproate in combination with ganciclovir induces lysis of EBV-infected lymphoma cells without impairing EBV-specific T-cell immunity.

Jones K, Nourse J, Corbett G, Gandhi MK. Jones K, et al. Int J Lab Hematol. 2010 Feb;32(1 Pt 1):e169-74. doi: 10.1111/j.1751-553X.2008.01130.x. Epub 2009 Jan 12. Int J Lab Hematol. 2010. PMID: 19196381

4

Epstein-Barr Virus-related post-transplant lymphoproliferative disorders: pathogenetic insights for targeted therapy.

Nourse JP, Jones K, Gandhi MK. Nourse JP, et al. Among authors: jones k. Am J Transplant. 2011 May;11(5):888-95. doi: 10.1111/j.1600-6143.2011.03499.x. Am J Transplant. 2011. PMID: 21521464 Free article. Review.

5

Epstein-Barr virus DNA as a biomarker for Epstein-Barr virus-positive lymphomas: are we there yet?

Jones K, Gandhi MK. Jones K, et al. Leuk Lymphoma. 2009 May;50(5):684-6. doi: 10.1080/10428190902847716. Leuk Lymphoma. 2009. PMID: 19330650 Review. No abstract available.

6

Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders.

Jones K, Nourse JP, Morrison L, Nguyen-Van D, Moss DJ, Burrows SR, Gandhi MK. Jones K, et al. Blood. 2010 Sep 30;116(13):2245-52. doi: 10.1182/blood-2010-03-274076. Epub 2010 Jun 18. Blood. 2010. PMID: 20562330 Free article.

7

Optimizing tumor-targeting chimeric antigen receptor T cells in B-cell lymphoma patients.

Gandhi M, Jones K. Gandhi M, et al. Among authors: jones k. Immunotherapy. 2011 Dec;3(12):1441-3. doi: 10.2217/imt.11.135. Immunotherapy. 2011. PMID: 22091680

8

Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma.

Jones K, Nourse JP, Keane C, Crooks P, Gottlieb D, Ritchie DS, Gill D, Gandhi MK. Jones K, et al. Am J Hematol. 2012 Mar;87(3):258-65. doi: 10.1002/ajh.22252. Epub 2011 Dec 27. Am J Hematol. 2012. PMID: 22213215 Free article.

9

Expression profiling of Epstein-Barr virus-encoded microRNAs from paraffin-embedded formalin-fixed primary Epstein-Barr virus-positive B-cell lymphoma samples.

Nourse JP, Crooks P, Keane C, Nguyen-Van D, Mujaj S, Ross N, Jones K, Vari F, Han E, Trappe R, Fink S, Gandhi MK. Nourse JP, et al. Among authors: jones k. J Virol Methods. 2012 Sep;184(1-2):46-54. doi: 10.1016/j.jviromet.2012.05.005. Epub 2012 May 16. J Virol Methods. 2012. PMID: 22609801

10

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.

Jones K, Vari F, Keane C, Crooks P, Nourse JP, Seymour LA, Gottlieb D, Ritchie D, Gill D, Gandhi MK. Jones K, et al. Clin Cancer Res. 2013 Feb 1;19(3):731-42. doi: 10.1158/1078-0432.CCR-12-2693. Epub 2012 Dec 5. Clin Cancer Res. 2013. PMID: 23224400

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,666 results

Search Page

Filters